Fujifilm, Exact Sciences & more: 4 GI company key notes

Here are four updates from gastroenterology companies this past week:

Advertisement

Five healthcare facilities recently signed on to adopt Fujifilm’s Eluxeo Endoscopic Visualization System, including two endoscopy centers and an ASC.

A phase 1 clinical trial found that Landos Biopharma’s Crohn’s disease and ulcerative colitis treatment, BT-11, was well-tolerated with no dose-limiting toxicities or detectable systemic immunosuppression.

Modernizing Medicine Gastroenterology improved its gGastro EHR through a collaboration with Change Healthcare.

Exact Sciences’ Cologuard can improve colorectal cancer screening rates, according to a study published in Gastroenterology.

More articles on gastroenterology: 
15 ASC company executive moves in 2019
12 ASC leadership tips — Delegation, change management & more
Mississippi clinic honors ASC nurse for going the extra mile — 3 highlights

Advertisement

Next Up in GI & Endoscopy

  • Renton, Wash.-based Providence has re-opened its North Coast Surgery Center in Oceanside, Calif., the Times Standard reported Feb. 5.  The…

  • Gastroenterology is rapidly transforming as health systems invest in outpatient digestive care, private equity-backed platforms expand and new technology reshapes…

  • AI’s early gains in gastroenterology are showing up in some of the most workflow-heavy parts of endoscopy — polyp detection,…

Advertisement

Comments are closed.